Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fran Seiwerth

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Opinion on Biological Therapy|September 17, 2024
Long-term progression-free survival in non-small cell lung cancer patients: a spotlight on bevacizumab and its biosimilarsFran Seiwerth, Lela Bitar, Miroslav Samaržija, et al.
Journal of Thoracic Disease|January 15, 2021
Immunotherapy for thymomaMarko Jakopovic, Lela Bitar, Fran Seiwerth, et al.
Antioxidants (Basel, Switzerland)|July 16, 2020
Mitochondrial ROS Induce Partial Dedifferentiation of Human Mesothelioma via Upregulation of NANOGFilip Sedlic, Fran Seiwerth, Ana Sepac, et al.
Diagnostic Pathology|September 23, 2016
Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in CroatiaLuka Brcic, Marko Jakopovic, Marija Misic, et al.
Croatian Medical Journal|May 8, 2020
Mitochondrial unfolded protein response, mitophagy and other mitochondrial quality control mechanisms in heart disease and aged heartTomo Svaguša, Mislav Martinić, Matea Martinić, et al.
Cancers|July 14, 2023
The Challenges and Opportunities of the Implementation of Comprehensive Genomic Profiling in Everyday Clinical Practice with Non-Small Cell Lung Cancer: National Results from CroatiaDora Čerina, Kristina Krpina, Marko Jakopović, et al.
Radiology and Oncology|September 4, 2023
Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysisLidija Ljubicic, Urska Janzic, Mojca Unk, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Biological Therapy|September 17, 2024
Long-term progression-free survival in non-small cell lung cancer patients: a spotlight on bevacizumab and its biosimilarsFran Seiwerth, Lela Bitar, Miroslav Samaržija, et al.
Journal of Thoracic Disease|January 15, 2021
Immunotherapy for thymomaMarko Jakopovic, Lela Bitar, Fran Seiwerth, et al.
Antioxidants (Basel, Switzerland)|July 16, 2020
Mitochondrial ROS Induce Partial Dedifferentiation of Human Mesothelioma via Upregulation of NANOGFilip Sedlic, Fran Seiwerth, Ana Sepac, et al.
Diagnostic Pathology|September 23, 2016
Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in CroatiaLuka Brcic, Marko Jakopovic, Marija Misic, et al.
Croatian Medical Journal|May 8, 2020
Mitochondrial unfolded protein response, mitophagy and other mitochondrial quality control mechanisms in heart disease and aged heartTomo Svaguša, Mislav Martinić, Matea Martinić, et al.
Cancers|July 14, 2023
The Challenges and Opportunities of the Implementation of Comprehensive Genomic Profiling in Everyday Clinical Practice with Non-Small Cell Lung Cancer: National Results from CroatiaDora Čerina, Kristina Krpina, Marko Jakopović, et al.
Radiology and Oncology|September 4, 2023
Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysisLidija Ljubicic, Urska Janzic, Mojca Unk, et al.
Pageof 1